CEMIP and cholangiocarcinoma: Previous results suggested that CEMIP might be a diagnostic marker for several cancers, such as cholangiocarcinoma (CCA), gastric cancer, and CRC.[60–62] As a secreted protein, overexpression of CEMIP is detected in serum levels in CCA patients before curative surgery.